LIVE MARKETS
--:--:-- ET
Testsite Thoughts, stories and ideas. 40 filings/day — zero noise
Regulatory ● Checked against the source
IONS

FDA Approves IONIS Drug Zanvastro for Alexander Disease

Ionis wins first-ever approval for a disease-modifying Alexander disease therapy, plus a rare pediatric disease priority review voucher.

DeskRegulatory
PublishedSep 4, 2026 · 10:40 ET
AccessPro story
Ionis' RNA-targeted therapy targets excess GFAP protein in the brain.
Source: Wikimedia